AbbVie Rg
ABBV
USD
STOCK MARKET:
NYX
Open
 
...
Large gap with delayed quotes
Last quote
04/21/2025 - 22:15:00
Bid
- - -
Bid
Volume
Ask
- - -
Ask
Volume
170.16
-2.83 ( -1.64% )
-
-
-
-
More information
Analysis by TheScreener
18.04.2025
Evaluation Positive  
Interest Very strong  
Sensibility Middle  
Analysis date: 18.04.2025
Global Evaluation
  Positive
The stock is classified in the positive zone since 18.04.2025.
Interest
  Very strong
Four stars since 18.04.2025.
Earnings Rev Trend
  Positive
 
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 15.04.2025 at a price of 176.80.
Evaluation
  Undervalued
 
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
  Negative
 
The stock appears oversold from a technical perspective due to its recent losses. It trades below its forty day technical trend since 04.04.2025.
4wk Rel Perf
  -12.52%
 
The stock appears oversold from a technical perspective, with a four week dividend-adjusted underperformance of of 12.52% behind the SP500.
Sensibility
  Middle
The stock has been on the moderate-sensitivity level since 28.02.2025.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -1.41%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 2.86%.
Mkt Cap in $bn
  306.02
With a market capitalization >$8bn, ABBVIE is considered a large-cap stock.
G/PE Ratio
  1.61
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
  9.19
The estimated PE is for the year 2029.
LT Growth
  10.91%
The annualized growth estimate is for the current year to 2029.
Avg. Nb analysts
  15
Over the last seven weeks, an average of 15 analysts provided earnings per share estimates.
Dividend Yield
  3.84%
The twelve month estimated dividend yield represents 35.30% of earnings forecasts.
Beta
  25
For 1% of index variation, the stock varies on average by 0.25%.
Correlation
  0.16
Stock movements are totally independent of index variations.
Value at Risk
  20.78
The value at risk is estimated at USD 20.78. The risk is therefore 12.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  05.04.2013